摘要
目的 探讨DNA疫苗pCI-S-IRES-ProT α接种小鼠后的免疫反应变化。方法用基因重组技术构建DNA疫苗,脂质体介导转染NIH-3T3细胞,并给小鼠进行DNA疫苗接种。ELISA检测HBsAg、抗-HBs,RT-PCR检测pCI-S-IRES-ProT α的表达。结果 pCI-S-IRES- ProT α、pCI-S在细胞中高效表达, pCI-S-IRES-ProT α接种小鼠产生的体液反应和特异T淋巴细胞增值反应强于pCI-S组。结论 ProT α可增强接种小鼠的免疫反应。
Objective: To investigate immune response in mice inoculated with DNA vaccine. Methods pCI-S and pCI-S-IRES-ProTα were constructed by gene technology, transferred into cell line NIH-3T3 mediated by lipofectamine. Mice were inoculated with these plasmids too. HBsAg and HBsAb were detected by ELISA, and transcriptions of these plasmids were detected by RT-PCR. Results pCI-S-IRES-ProTα, and pCI-S were effectively expressed in cultured cells and vaccinated animals. Humoral immune and specific T-cell proliferative responses were stronger in pCI- SIRES group than pCL-S group. Conclusions Plasmids coexpression of prothymosin α and hepatitis B surface antigen can improve immune responses significantly.
出处
《中华肝脏病杂志》
CAS
CSCD
2001年第2期108-110,共3页
Chinese Journal of Hepatology
基金
国家自然科学基金!(39770680)
上海市博士点基金